These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

803 related items for PubMed ID: 22921712

  • 1. [Kawasaki disease: what you need to know].
    Bajolle F, Laux D.
    Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series.
    Mori M, Imagawa T, Hara R, Kikuchi M, Hara T, Nozawa T, Miyamae T, Yokota S.
    J Rheumatol; 2012 Apr; 39(4):864-7. PubMed ID: 22337241
    [Abstract] [Full Text] [Related]

  • 3. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC.
    Lancet; 2014 May 17; 383(9930):1731-8. PubMed ID: 24572997
    [Abstract] [Full Text] [Related]

  • 4. Infliximab as a novel therapy for refractory Kawasaki disease.
    Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS.
    J Rheumatol; 2004 Apr 17; 31(4):808-10. PubMed ID: 15088313
    [Abstract] [Full Text] [Related]

  • 5. The effect of TNFalpha blockade in complicated, refractory Kawasaki disease.
    Stenbøg EV, Windelborg B, Hørlyck A, Herlin T.
    Scand J Rheumatol; 2006 Apr 17; 35(4):318-21. PubMed ID: 16882598
    [Abstract] [Full Text] [Related]

  • 6. Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience.
    Singh-Grewal D, Wong M, Isaacs D.
    J Paediatr Child Health; 2005 Apr 17; 41(9-10):495-9. PubMed ID: 16150066
    [Abstract] [Full Text] [Related]

  • 7. The diagnosis and management of Kawasaki disease.
    Royle J, Burgner D, Curtis N.
    J Paediatr Child Health; 2005 Mar 17; 41(3):87-93. PubMed ID: 15790316
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
    Arthritis Rheum; 2013 Mar 17; 65(3):805-14. PubMed ID: 23440694
    [Abstract] [Full Text] [Related]

  • 9. Infections and Kawasaki disease: implications for coronary artery outcome.
    Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS.
    Pediatrics; 2005 Dec 17; 116(6):e760-6. PubMed ID: 16322132
    [Abstract] [Full Text] [Related]

  • 10. A 12-week-old male with a 10-day history of fever.
    Bhatt ST, Hageman JR, Bartlett A, Trivedi K.
    Pediatr Ann; 2014 May 17; 43(5):e111-5. PubMed ID: 24877492
    [Abstract] [Full Text] [Related]

  • 11. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb 17; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 12. Infliximab treatment for refractory Kawasaki syndrome.
    Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, Balfour I, Shen CA, Michel ED, Shulman ST, Melish ME.
    J Pediatr; 2005 May 17; 146(5):662-7. PubMed ID: 15870671
    [Abstract] [Full Text] [Related]

  • 13. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec 17; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 14. Kawasaki disease: part II. Complications and treatment.
    Bayers S, Shulman ST, Paller AS.
    J Am Acad Dermatol; 2013 Oct 17; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
    [Abstract] [Full Text] [Related]

  • 15. Long-term prognosis of Kawasaki disease: increased cardiovascular risk?
    Fukazawa R.
    Curr Opin Pediatr; 2010 Oct 17; 22(5):587-92. PubMed ID: 20717036
    [Abstract] [Full Text] [Related]

  • 16. Kawasaki disease: diagnosis, management, and long-term implications.
    Satou GM, Giamelli J, Gewitz MH.
    Cardiol Rev; 2007 Oct 17; 15(4):163-9. PubMed ID: 17575479
    [Abstract] [Full Text] [Related]

  • 17. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM, Shulman ST.
    J Clin Pharm Ther; 2015 Dec 17; 40(6):620-5. PubMed ID: 26547265
    [Abstract] [Full Text] [Related]

  • 18. Recent developments and controversies in Kawasaki disease.
    Guzman-Cottrill JA, Shulman ST.
    Minerva Pediatr; 2004 Feb 17; 56(1):51-61. PubMed ID: 15249914
    [Abstract] [Full Text] [Related]

  • 19. Update on the treatment of Kawasaki disease in childhood.
    Sundel RP.
    Curr Rheumatol Rep; 2002 Dec 17; 4(6):474-82. PubMed ID: 12427361
    [Abstract] [Full Text] [Related]

  • 20. A national survey on the pediatric cardiologist's clinical approach for patients with Kawasaki disease.
    Kahwaji IY, Connuck DM, Tafari N, Dahdah NS.
    Pediatr Cardiol; 2002 Dec 17; 23(6):639-46. PubMed ID: 12530498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.